Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A W Partin

Showing results (221-230 of 234) with videos related to

Pageof 24
Sort By:
Urology|March 30, 1999
Long-term effects of finasteride on prostate tissue compositionL S Marks, A W Partin, F J Dorey, et al.
Urology|November 24, 1999
Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysisA W Partin, W J Catalona, J A Finlay, et al.
Urology|December 22, 1999
Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancerM J Manyak, G H Hinkle, J O Olsen, et al.
Urology|December 1, 1996
Multicenter comparison of the diagnostic performance of free prostate-specific antigenR P Thiel, J E Oesterling, K J Wojno, et al.
Prostate Cancer and Prostatic Diseases|January 25, 2017
Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practiceJ J Tosoian, S C Druskin, D Andreas, et al.
The Journal of Urology|February 7, 2001
Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancerM K Brawer, C D Cheli, I E Neaman, et al.
The Prostate|December 16, 1997
Comparison of serum PSMA, PSA levels with results of Cytogen-356 ProstaScint scanning in prostatic cancer patientsG P Murphy, R T Maguire, B Rogers, et al.
The Journal of Urology|February 7, 2001
Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasiaL S Marks, A W Partin, J I Epstein, et al.
The Journal of Urology|September 24, 1999
Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trialP C Southwick, W J Catalona, A W Partin, et al.
Urology|August 5, 2000
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and stagingW J Catalona, P C Southwick, K M Slawin, et al.
Pageof 24

Showing results (221-230 of 234) with videos related to

Sort By:
Pageof 24
Urology|March 30, 1999
Long-term effects of finasteride on prostate tissue compositionL S Marks, A W Partin, F J Dorey, et al.
Urology|November 24, 1999
Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysisA W Partin, W J Catalona, J A Finlay, et al.
Urology|December 22, 1999
Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancerM J Manyak, G H Hinkle, J O Olsen, et al.
Urology|December 1, 1996
Multicenter comparison of the diagnostic performance of free prostate-specific antigenR P Thiel, J E Oesterling, K J Wojno, et al.
Prostate Cancer and Prostatic Diseases|January 25, 2017
Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practiceJ J Tosoian, S C Druskin, D Andreas, et al.
The Journal of Urology|February 7, 2001
Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancerM K Brawer, C D Cheli, I E Neaman, et al.
The Prostate|December 16, 1997
Comparison of serum PSMA, PSA levels with results of Cytogen-356 ProstaScint scanning in prostatic cancer patientsG P Murphy, R T Maguire, B Rogers, et al.
The Journal of Urology|February 7, 2001
Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasiaL S Marks, A W Partin, J I Epstein, et al.
The Journal of Urology|September 24, 1999
Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trialP C Southwick, W J Catalona, A W Partin, et al.
Urology|August 5, 2000
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and stagingW J Catalona, P C Southwick, K M Slawin, et al.
Pageof 24